Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-06
C
Claire Doshier
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Vanderbilt University (2021–2024)
3 h-index
59 pubs
22 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Claire Doshier's research focuses on oncogenic pathways and therapeutic targets in lymphoma. Her work has identified NIMA-related kinase 2 (NEK2) as a potential therapeutic target and regulator of these pathways, as indicated by her recent publication on a bifunctional inhibitor. She has also investigated the role of damage-induced senescent immune cells in tissue regeneration, specifically within the zebrafish retina. Doshier has a substantial publication record, with 59 total publications and an h-index of 3. She has collaborated extensively with colleagues at the University of Arkansas for Medical Sciences, including Vijay Patel, Mason McCrury, Kennith Swafford, and Sydnye L. Shuttleworth, with whom she shares numerous publications.
Metrics
- h-index: 3
- Publications: 59
- Citations: 22
Selected Publications
-
DNA secondary structures in BCL2 and MYC elicit activation-induced cytidine deaminase binding and activity (2026)
Collaboration Network
Top Collaborators
Mason McCrury
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- DNA secondary structures in BCL2 and MYC elicit activation-induced cytidine deaminase binding and activity
Samantha Kendrick
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- DNA secondary structures in BCL2 and MYC elicit activation-induced cytidine deaminase binding and activity
Kennith Swafford
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Sydnye L. Shuttleworth
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Syed Hassan Mehdi
University of Arkansas Medical Center
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Baku Acharya
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Debasmita Saha
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Kevin Naceanceno
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Stephanie D. Byrum
Arkansas Children's Hospital
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Aaron J. Storey
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Ying-Zhi Xu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Vijay Patel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Ginell R. Post
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Annick De Loose
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Analiz Rodriguez
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Similar Researchers
Based on overlapping research topics
Mina Khoshaba
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Ginell Ristic Post
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Sydnye L. Shuttleworth
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Vijay Patel
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Henry Ν. C. Wong
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Thomas J. Kelly
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Immune Response and Inflammation